Skip to content

Evaluation of the effect of champ-ix in smoking cessation

Evaluation of the effect of champ-ix in smoking cessation in smokers in Tehran

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138901111878N2
Enrollment
90
Registered
2010-10-12
Start date
2010-05-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

quit smoking. Mental and behavioural disorders due to use of tobacco

Interventions

Intervention 1: Brief advice. Intervention 2: nicotine patches 15 mg for 8 weeks. Intervention 3: Varnicilin tablet 1 mg for 8 weeks.
Treatment - Drugs
Varnicilin tablet 1 mg for 8 weeks
Brief advice
nicotine patches 15 mg for 8 weeks

Sponsors

Tobacco prevention & control research center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: being a smoker and ready to quit

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quit smoking. Timepoint: 1-3-6-12 months. Method of measurement: co expiratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Heydari

Tobacco prevention & control research center

ghrheydari@nritld.ac.ir+98 21 2610 6003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026